Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Non-Interventional Weight Changes Are Associated with Alterations in Serum Uric Acid Levels.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI AG, [2012]-
    • نبذة مختصرة :
      Background/Objectives : Serum uric acid is an established cardiovascular risk factor. Higher serum uric acid levels are associated with overweight and obesity. We assessed whether non-interventional weight changes affect serum uric acid levels. Methods : We performed a retrospective analysis of 19,193 participants referred to annual medical screening. Body mass index (BMI) and serum uric acid were measured annually. Subjects were divided into five groups according to changes in BMI between visits: large reduction (reduction of more than 5% in BMI), moderate reduction (reduction of more than 2.5% and 5% or less in BMI), unchanged (up to 2.5% change in BMI), moderate increase (increase of more than 2.5% and 5% or less in BMI), and large increase (increase of more than 5% in BMI). The primary outcome was serum uric acid level changes between visits. Results : A decrease in serum uric acid levels was evident as BMI decreased and an increase in serum uric acid levels was associated with an increase in BMI. The proportion of patients whose serum uric acid levels were increased by at least 10% between visits increased with the relative increase in BMI, while the proportion of patients whose serum uric acid levels were reduced by at least 10% decreased with the relative decrease in BMI. Conclusions : Non-interventional weight changes, even modest, are associated with significant alterations in serum uric acid levels. Our findings may aid in better risk stratification and the primary prevention of cardiovascular morbidity and mortality.
    • References:
      J Public Health (Oxf). 2018 Jun 1;40(2):253-261. (PMID: 28525566)
      Front Pharmacol. 2020 Nov 16;11:582680. (PMID: 33304270)
      J Hypertens. 2008 Feb;26(2):269-75. (PMID: 18192841)
      Cureus. 2021 May 5;13(5):e14855. (PMID: 34104597)
      Metabolism. 1998 Aug;47(8):929-33. (PMID: 9711987)
      Int J Cardiol. 2018 Feb 15;253:167-173. (PMID: 29306459)
      Am J Epidemiol. 1997 Aug 1;146(3):214-22. (PMID: 9247005)
      J Clin Endocrinol Metab. 2024 Mar 14;:. (PMID: 38482609)
      Ann Intern Med. 1999 Jul 6;131(1):7-13. (PMID: 10391820)
      Nutr Metab (Lond). 2004 Oct 19;1(1):10. (PMID: 15507132)
      Circulation. 1983 May;67(5):968-77. (PMID: 6219830)
      Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009348. (PMID: 36974678)
      N Engl J Med. 2009 Feb 26;360(9):859-73. (PMID: 19246357)
      Lancet. 2014 Mar 15;383(9921):970-83. (PMID: 24269108)
      Diabetes Care. 2020 Nov;43(11):2812-2820. (PMID: 33082244)
      Eur Heart J. 2010 Mar;31(6):737-46. (PMID: 19933515)
      PLoS One. 2019 Aug 5;14(8):e0220532. (PMID: 31381584)
      Hypertension. 2017 Feb;69(2):236-242. (PMID: 27993955)
      BMC Endocr Disord. 2020 Jan 6;20(1):2. (PMID: 31906920)
      J Clin Hypertens (Greenwich). 2021 May;23(5):990-998. (PMID: 33675167)
      Ann Rheum Dis. 2017 Nov;76(11):1870-1882. (PMID: 28866649)
      Diabetes Care. 1997 Jun;20(6):978-82. (PMID: 9167109)
      Heart. 2021 Sep;107(17):1429-1434. (PMID: 33219107)
      N Engl J Med. 2017 Jul 6;377(1):13-27. (PMID: 28604169)
      Nutrients. 2018 Aug 03;10(8):. (PMID: 30081468)
      Circulation. 2021 May 25;143(21):e984-e1010. (PMID: 33882682)
      Arch Intern Med. 1975 Dec;135(12):1575-84. (PMID: 1200726)
      Eur J Prev Cardiol. 2023 May 9;30(7):524-532. (PMID: 36378558)
      Nutrients. 2024 Feb 08;16(4):. (PMID: 38398811)
      Am J Kidney Dis. 2007 Aug;50(2):239-47. (PMID: 17660025)
      Ann Intern Med. 2023 Jan;176(1):10-21. (PMID: 36508737)
      Endocr Pract. 2019 May;25(5):438-445. (PMID: 30657365)
      Clin Pharmacol Ther. 2024 Feb 23;:. (PMID: 38389505)
      Int J Gen Med. 2021 Nov 12;14:8065-8071. (PMID: 34795514)
      Diabetes Metab Syndr Obes. 2021 Feb 11;14:627-635. (PMID: 33603427)
      Obesity (Silver Spring). 2015 Apr;23(4):879-85. (PMID: 25755157)
      Diabetes Care. 2009 Sep;32(9):1716-20. (PMID: 19542211)
      Cell Rep Med. 2022 Oct 18;3(10):100777. (PMID: 36220069)
      Front Nutr. 2022 Apr 18;9:773220. (PMID: 35520285)
      Ther Adv Musculoskelet Dis. 2021 Feb 24;13:1759720X21993253. (PMID: 33708266)
      Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):79-82. (PMID: 16088970)
      Front Pediatr. 2022 Jan 04;9:814166. (PMID: 35059366)
      RMD Open. 2019 Oct 13;5(2):e001015. (PMID: 31673414)
      Hypertension. 2020 Feb;75(2):302-308. (PMID: 31813345)
      Hypertension. 2003 Jun;41(6):1183-90. (PMID: 12707287)
    • Contributed Indexing:
      Keywords: BMI; body mass index; uric acid; weight changes
    • الموضوع:
      Date Created: 20240427 Latest Revision: 20240429
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC11051435
    • الرقم المعرف:
      10.3390/jcm13082314
    • الرقم المعرف:
      38673586